Compound half-life reference

Every plottable compound in the dataset, sortable by half-life. Values are the same numbers the plotter uses — measured where published data exists, flagged as estimates in the individual compound pages where it doesn't. Click a column header to sort.

Compound	Half-life	Group	Typical dose	Detection window	Evidence
Testosterone Enanthate	7.2 days	Testosterone Esters	100–600 mg	60–90 d	Human RCT
Testosterone Cypionate	6.9 days	Testosterone Esters	100–600 mg	60–90 d	Human RCT
Testosterone Propionate	2 days	Testosterone Esters	50–150 mg	14–21 d	Human clinical
Testosterone Undecanoate (Castor Oil)	34 days	Testosterone Esters	750–1000 mg	—	Human RCT
Testosterone Undecanoate (MCT Oil)	20 days	Testosterone Esters	500–1000 mg	—	Human RCT
Testosterone Undecanoate (Oral)	18.4 hours	Testosterone Esters	158–396 mg	—	Human clinical
Testosterone Phenylpropionate	2.5 days	Testosterone Esters	50–200 mg	—	Human clinical
Testosterone Isocaproate	3.1 days	Testosterone Esters	50–200 mg	—	Human clinical
Testosterone Suspension	33 hours	Testosterone Esters	25–100 mg	—	Human clinical
Testosterone Decanoate	5.6 days	Testosterone Esters	100–300 mg	—	Human clinical
Testosterone Gel (Testogel/AndroGel)	3 days	Testosterone Preparations	25–100 mg	—	Human RCT
Testosterone Base (Sublingual)	37 min	Testosterone Preparations	12.5–50 mg	—	Human clinical
Boldenone Cypionate	6.9 days	Boldenone	150–400 mg	—	Preclinical
Estradiol Topical (EstroGel)	36 hours	Estrogens	0.5–1.5 mg	—	Human RCT
Estradiol Cypionate	3.7 days	Estrogens	2–10 mg	—	Human clinical
Estradiol Valerate	3.5 days	Estrogens	2–10 mg	—	Human clinical
Progesterone (Oral)	22.8 hours	Progestins	100–300 mg	—	Human RCT
Progesterone (Vaginal)	20.7 hours	Progestins	100–400 mg	—	Human RCT
T3 (Triiodothyronine)	22.0 hours	Thyroid	25–75 mcg	—	Human clinical
Trenbolone Enanthate	11 days	Trenbolone	150–400 mg	30–60 d	Preclinical
Trenbolone Acetate	36 hours	Trenbolone	35–100 mg	20–35 d	Preclinical
Trenbolone Hexahydrobenzylcarbonate	8 days	Trenbolone	100–300 mg	30–60 d	Preclinical
Trestolone Acetate (MENT)	3.7 hours	Trestolone	10–50 mg	—	Human clinical
Masteron Propionate	2 days	Drostanolone	50–150 mg	—	Human clinical
Masteron Enanthate	8 days	Drostanolone	200–400 mg	—	Human clinical
Mesterolone (Proviron)	12.5 hours	DHT Derivatives (Oral)	25–100 mg	—	Human clinical
Nandrolone Phenylpropionate	2.4 days	Nandrolone	50–200 mg	60–120 d	Human clinical
Nandrolone Decanoate	10 days	Nandrolone	100–400 mg	120–270 d	Human clinical
Boldenone Undecylenate (Equipoise)	14 days	Boldenone	200–600 mg	90–180 d	Preclinical
Dihydroboldenone (DHB)	9 days	Boldenone	100–300 mg	—	Anecdotal
Primobolan (Oral)	5.0 hours	Methenolone	25–100 mg	—	Human clinical
Primobolan (Injectable)	11 days	Methenolone	200–400 mg	21–40 d	Human clinical
Halotestin	2.0 hours	Oral AAS	5–30 mg	7–14 d	Human clinical
Anadrol	8.0 hours	Oral AAS	25–100 mg	21–42 d	Human clinical
Dianabol	5.3 hours	Oral AAS	15–50 mg	28–42 d	Human clinical
Turinabol	16.0 hours	Oral AAS	20–60 mg	28–42 d	Human clinical
Winstrol (Oral)	9 hours	Oral AAS	20–50 mg	21–42 d	Human clinical
Winstrol (Injectable)	3.4 days	Injectable AAS	50–100 mg	42–63 d	Human clinical
Anavar	9.5 hours	Oral AAS	10–50 mg	21–28 d	Human clinical
Superdrol	10.0 hours	Oral AAS	10–30 mg	7–11 d	Human clinical
HCG	47.1 hours	Gonadotropins	0.25–1 mg	—	Human clinical
Human Growth Hormone (HGH)	4.1 hours	Growth Hormone	0.5–4 mg	—	Human RCT
Semaglutide Injection (Ozempic/Wegovy)	6.5 days	GLP-1 Agonists	0.25–2.4 mg	—	Human RCT
Semaglutide Oral (Rybelsus)	13.0 hours	GLP-1 Agonists	3–14 mg	—	Human RCT
Tirzepatide (Mounjaro)	4.9 days	GLP-1 / GIP Agonists	2.5–15 mg	—	Human RCT
Retatrutide	6.1 days	GLP-1 / GIP / Glucagon Agonists	1–12 mg	—	Human clinical
Mazdutide	18 days	GLP-1 / Glucagon Agonists	3–9 mg	—	Human RCT
DNP	3.7 days	Chemicals	50–200 mg	—	Human clinical
Arimidex (Anastrozole)	46.8 hours	Aromatase Inhibitors	0.25–1 mg	—	Human RCT
Aromasin (Exemestane)	22.7 hours	Aromatase Inhibitors	6.25–25 mg	—	Human RCT
Clenbuterol (Oral)	26.6 hours	Fat Loss Agents	20–120 mcg	7–14 d	Human clinical
Nolvadex (Tamoxifen)	47.4 hours	SERMs	10–40 mg	—	Human RCT
Clomid (Clomiphene)	5 days	SERMs	25–100 mg	—	Human RCT
Cabergoline	3.6 days	Dopamine Agonists	0.125–1 mg	—	Human RCT
Letrozole	33.3 hours	Aromatase Inhibitors	0.625–2.5 mg	—	Human RCT
Nebivolol	16.9 hours	Cardiovascular	2.5–20 mg	—	Human RCT
Telmisartan	23.3 hours	Cardiovascular	20–80 mg	—	Human RCT
Tadalafil	17.0 hours	PDE5 Inhibitors	2.5–20 mg	—	Human RCT
Ostarine (MK-2866 / Enobosarm)	24 hours	SARMs	10–25 mg	6–9 d	Human clinical
Ligandrol (LGD-4033)	30 hours	SARMs	2–10 mg	14–21 d	Human clinical
Andarine (S4)	3.9 hours	SARMs	12.5–50 mg	3–6 d	Preclinical
Testolone (RAD-140)	44.7 hours	SARMs	5–20 mg	5–9 d	Human clinical
Cardarine (GW-501516)	20 hours	PPARδ Agonists	5–20 mg	30–40 d	Preclinical
S-23	4 hours	SARMs	5–30 mg	15–21 d	Preclinical
Cagrilintide	6.5 days	Amylin Agonists	0.16–2.4 mg	—	Human clinical
Dulaglutide (Trulicity)	5 days	GLP-1 Agonists	0.75–4.5 mg	—	Human RCT
Pramlintide (Symlin)	43 min	Amylin Agonists	15–120 mcg	—	Human RCT
Survodutide	6 days	GLP-1 / Glucagon Agonists	0.72–9.6 mg	—	Human clinical
5-Amino-1MQ	12 hours	Metabolic Research	25–100 mg	—	Preclinical
Adipotide	58 min	Weight Loss Research	1–5 mg	—	Preclinical
HGH Fragment 176-191 (AOD-9604)	12 hours	Growth Hormone Fragments	0.25–1 mg	—	Human clinical
MGF (Mechano Growth Factor)	29 min	IGF / MGF	200–800 mcg	2–5 d	Preclinical
PEG-MGF (Pegylated MGF)	19.2 hours	IGF / MGF	200–800 mcg	—	Preclinical
IGF-1 DES	29 min	IGF / MGF	25–100 mcg	—	Preclinical
IGF-1 LR3	12 hours	IGF / MGF	20–100 mcg	—	Preclinical
CJC-1295 with DAC	8 days	GHRH Secretagogues	1–3 mg	—	Human clinical
CJC-1295 without DAC (Modified GRF 1-29)	29 min	GHRH Secretagogues	100–500 mcg	—	Preclinical
Ipamorelin	1.9 hours	GHRP Secretagogues	100–500 mcg	—	Human clinical
Sermorelin	14 min	GHRH Secretagogues	150–500 mcg	—	Human clinical
Tesamorelin	29 min	GHRH Secretagogues	1–2 mg	—	Human RCT
GHRP-2	58 min	GHRP Secretagogues	100–300 mcg	—	Human clinical
GHRP-6	58 min	GHRP Secretagogues	100–300 mcg	—	Human clinical
MK-677 (Ibutamoren)	5 hours	GHRP Secretagogues	10–25 mg	—	Human clinical
ACE-031	3 days	Myostatin Research	0.5–3 mg	—	Human clinical
AICAR	4.8 hours	Metabolic Research	10–50 mg	2–5 d	Human clinical
EPO (Erythropoietin)	9.6 hours	Erythropoiesis	5–20 mcg	3–7 d	Human RCT
HMG (Menotropin)	36 hours	Gonadotropins	75–300 mcg	—	Human RCT
Gonadorelin Acetate	10 min	Gonadotropins	50–500 mcg	—	Human clinical
Kisspeptin	29 min	Gonadotropins	0.25–1 mg	—	Human clinical
BPC-157	4.1 hours	Healing Peptides	0.25–1 mg	—	Preclinical
TB-500 (Thymosin Beta-4)	1.9 hours	Healing Peptides	0.25–2.5 mg	—	Preclinical
TB-500 Fragment	58 min	Healing Peptides	100–500 mcg	—	Preclinical
Thymosin Alpha-1	2.9 hours	Immune Peptides	0.8–3.2 mg	—	Human clinical
ARA-290 (Cibinetide)	12 hours	Healing Peptides	2–8 mg	—	Human clinical
SS-31 (Elamipretide)	1.9 hours	Mitochondrial Peptides	2–8 mg	—	Human clinical
MOTS-c	12 hours	Mitochondrial Peptides	2.5–10 mg	—	Preclinical
Dermorphin	29 min	Analgesic Peptides	5–20 mcg	—	Preclinical
Cerebrolysin	58 min	Nootropic Peptides	1–10 mg	—	Human clinical
Cartalax	4.1 hours	Bioregulator Peptides	0.5–2 mg	—	Preclinical
Prostamax	4.1 hours	Bioregulator Peptides	0.5–2 mg	—	Preclinical
Testagen	4.1 hours	Bioregulator Peptides	0.5–2 mg	—	Preclinical
Vesugen	4.1 hours	Bioregulator Peptides	0.5–2 mg	—	Preclinical
L-Carnitine (Injectable)	14.4 hours	Metabolic Nutrients	50–500 mg	—	Human clinical
SLU-PP-332	4.8 hours	Metabolic Research	5–30 mg	—	Preclinical

Detection windows are literature-sourced anti-doping estimates for the long-lived metabolites assays target — provided for educational context, not for evading testing. Educational use only — not medical advice.